Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome)

Clinical Immunology

Volumn 136, Issue 3, 2010, Pages 409-418

  Zemble, R ^a   Luning Prak, E ^b   McDonald, K ^c   McDonald McGinn, D ^c   Zackai, E ^c   Sullivan, K ^c  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Allergy; Antibody; Autoimmunity; B cells; DiGeorge syndrome; Th1; Th17; Th2

Indexed keywords

ADULT; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CHILD; CHROMOSOME 22Q; CHROMOSOME DELETION; CONTROLLED STUDY; DIGEORGE SYNDROME; DISEASE PREDISPOSITION; HOMEOSTASIS; HUMAN; IMMUNE SYSTEM; IMMUNOPHENOTYPING; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MEMORY CELL; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; TH1 CELL; TH17 CELL; TH2 CELL; TODDLER; VELOCARDIOFACIAL SYNDROME;

EID: 77955272462     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2010.04.011     Document Type: Article

References (80)

1. Lindsay E.A., Vitelli F., Su H., Morishima M., Huynh T., Pramparo T., Jurecic V., Ogunrinu G., Sutherland H.F., Scambler P.J., Bradley A., Baldini A. Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 2001, 410:97-101.
2. Jerome L.A., Papaioannou V.E. DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nat. Genet. 2001, 27:286-291.
3. Driscoll D.A., Salvin J., Sellinger B., Budarf M.L., McDonald-McGinn D.M., Zackai E.H., Emanuel B.S. Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counselling and prenatal diagnosis. J. Med. Genet. 1993, 30:813-817.
4. Ravnan J.B., Chen E., Golabi M., Lebo R.V. Chromosome 22q11.2 microdeletions in velocardiofacial syndrome patients with widely variable manifestations. Am. J. Med. Genet. 1996, 66:250-256.
5. Yagi H., Furutani Y., Hamada H., Sasaki T., Asakawa S., Minoshima S., Ichida F., Joo K., Kimura M., Imamura S., Kamatani N., Momma K., Takao A., Nakazawa M., Shimizu N., Matsuoka R. Role of TBX1 in human del22q11.2 syndrome. Lancet 2003, 362:1366-1373.
6. Torres-Juan L., Rosell J., Morla M., Vidal-Pou C., Garcia-Algas F., de la Fuente M.A., Juan M., Tubau A., Bachiller D., Bernues M., Perez-Granero A., Govea N., Busquets X., Heine-Suner D. Mutations in TBX1 genocopy the 22q11.2 deletion and duplication syndromes: a new susceptibility factor for mental retardation. Eur. J. Hum. Genet. 2007, 15:658-663.
7. Xu H., Cerrato F., Baldini A. Timed mutation and cell-fate mapping reveal reiterated roles of Tbx1 during embryogenesis, and a crucial function during segmentation of the pharyngeal system via regulation of endoderm expansion. Development 2005, 132:4387-4395.
8. Merscher S., Funke B., Epstein J.A., Heyer J., Puech A., Lu M.M., Xavier R.J., Demay M.B., Russell R.G., Factor S., Tokooya K., Jore B.S., Lopez M., Pandita R.K., Lia M., Carrion D., Xu H., Schorle H., Kobler J.B., Scambler P., Wynshaw-Boris A., Skoultchi A.I., Morrow B.E., Kucherlapati R. TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 2001, 104:619-629.
9. Vitelli F., Morishima M., Taddei I., Lindsay E.A., Baldini A. Tbx1 mutation causes multiple cardiovascular defects and disrupts neural crest and cranial nerve migratory pathways. Hum. Mol. Genet. 2002, 11:915-922.
10. Zhang Z., Cerrato F., Xu H., Vitelli F., Morishima M., Vincentz J., Furuta Y., Ma L., Martin J.F., Baldini A., Lindsay E. Tbx1 expression in pharyngeal epithelia is necessary for pharyngeal arch artery development. Development 2005, 132:5307-5315.
11. McDonald-McGinn D.M., Kirschner R., Goldmuntz E., Sullivan K., Eicher P., Gerdes M., Moss E., Solot C., Wang P., Jacobs I., Handler S., Knightly C., Heher K., Wilson M., Ming J.E., Grace K., Driscoll D., Pasquariello P., Randall P., Larossa D., Emanuel B.S., Zackai E.H. The Philadelphia story: the 22q11.2 deletion: report on 250 patients. Genet. Couns. 1999, 10:11-24.
12. Goodship J., Cross I., LiLing J., Wren C. A population study of chromosome 22q11 deletions in infancy. Arch. Dis. Child. 1998, 79:348-351.
13. Matsuoka R., Takao A., Kimura M., Imamura S., Kondo C., Joh-o K., Ikeda K., Nishibatake M., Ando M., Momma K. Confirmation that the conotruncal anomaly face syndrome is associated with a deletion within 22q11.2. Am. J. Med. Genet. 1994, 53:285-289.
14. Ryan A.K., Goodship J.A., Wilson D.I., Philip N., Levy A., Seidel H., Schuffenhauer S., Oechsler H., Belohradsky B., Prieur M., Aurias A., Raymond F.L., Clayton-Smith J., Hatchwell E., McKeown C., Beemer F.A., Dallapiccola B., Novelli G., Hurst J.A., Ignatius J., Green A.J., Winter R.M., Brueton L., Brondum-Nielson K., Stewart F., Van Essen T., Patton M., Paterson J., Scambler P.J. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J. Med. Genet. 1997, 34:798-804.
15. Bassett A.S., Chow E.W., Husted J., Weksberg R., Caluseriu O., Webb G.D., Gatzoulis M.A. Clinical features of 78 adults with 22q11 deletion syndrome. Am. J. Med. Genet. 2005, 138:307-313.
16. Oskarsdottir S., Persson C., Eriksson B.O., Fasth A. Presenting phenotype in 100 children with the 22q11 deletion syndrome. Eur. J. Pediatr. 2005, 164:146-153.
17. Jawad A.F., McDonald-McGinn D.M., Zackai E., Sullivan K.E. Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). J. Pediatr. 2001, 139:715-723.
18. Barrett D.J., Ammann A.J., Wara D.W., Cowan M.J., Fisher T.J., Stiehm E.R. Clinical and immunologic spectrum of the DiGeorge syndrome. J. Clin. Lab. Immunol. 1981, 6:1-6.
19. Conley M.E., Beckwith J.B., Mancer J.F., Tenckhoff L. The spectrum of the DiGeorge syndrome. J. Pediatr. 1979, 94:883-890.
20. Bastian J., Law S., Vogler L., Lawton A., Herrod H., Anderson S., Horowitz S., Hong R. Prediction of persistent immunodeficiency in the DiGeorge anomaly. J. Pediatr. 1989, 115:391-396.
21. Muller W., Peter H.H., Kallfelz H.C., Franz A., Rieger C.H. The DiGeorge sequence. II. Immunologic findings in partial and complete forms of the disorder. Eur. J. Pediatr. 1989, 149:96-103.
22. Muller W., Peter H.H., Wilken M., Juppner H., Kallfelz H.C., Krohn H.P., Miller K., Rieger C.H. The DiGeorge syndrome. I. Clinical evaluation and course of partial and complete forms of the syndrome. Eur. J. Pediatr. 1988, 147:496-502.
23. Sediva A., Bartunkova J., Zachova R., Polouckova A., Hrusak O., Janda A., Kocarek E., Novotna D., Novotna K., Klein T. Early development of immunity in diGeorge syndrome. Med. Sci. Monit. 2005, 11:CR182-7.
24. Kanaya Y., Ohga S., Ikeda K., Furuno K., Ohno T., Takada H., Kinukawa N., Hara T. Maturational alterations of peripheral T cell subsets and cytokine gene expression in 22q11.2 deletion syndrome. Clin. Exp. Immunol. 2006, 144:85-93.
25. Chinen J., Rosenblatt H.M., Smith E.O., Shearer W.T., Noroski L.M. Long-term assessment of T-cell populations in DiGeorge syndrome. J. Allergy Clin. Immunol. 2003, 111:573-579.
26. Piliero L.M., Sanford A.N., McDonald-McGinn D.M., Zackai E.H., Sullivan K.E. T-cell homeostasis in humans with thymic hypoplasia due to chromosome 22q11.2 deletion syndrome. Blood 2004, 103:1020-1025.
27. Boyman O., Letourneau S., Krieg C., Sprent J. Homeostatic proliferation and survival of naive and memory T cells. Eur. J. Immunol. 2009, 39:2088-2094.
28. Boyman O., Purton J.F., Surh C.D., Sprent J. Cytokines and T-cell homeostasis. Curr. Opin. Immunol. 2007, 19:320-326.
29. Kieper W.C., Jameson S.C. Homeostatic expansion and phenotypic conversion of naive T cells in response to self peptide/MHC ligands. Proc. Natl. Acad. Sci. USA 1999, 96:13306-13311.
30. Jameson S.C. Maintaining the norm: T-cell homeostasis. Nat. Rev. Immunol. 2002, 2:547-556.
31. Prlic M., Blazar B.R., Khoruts A., Zell T., Jameson S.C. Homeostatic expansion occurs independently of costimulatory signals. J. Immunol. 2001, 167:5664-5668.
32. Tan J.T., Ernst B., Kieper W.C., LeRoy E., Sprent J., Surh C.D. Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J. Exp. Med. 2002, 195:1523-1532.
33. Tan J.T., Dudl E., LeRoy E., Murray R., Sprent J., Weinberg K.I., Surh C.D. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc. Natl. Acad. Sci. USA 2001, 98:8732-8737.
34. Sprent J., Cho J.H., Boyman O., Surh C.D. T cell homeostasis. Immunol. Cell Biol. 2008, 86:312-319.
35. Milner J.D., Ward J.M., Keane-Myers A., Paul W.E. Lymphopenic mice reconstituted with limited repertoire T cells develop severe, multiorgan, Th2-associated inflammatory disease. Proc. Natl. Acad. Sci. USA 2007, 104:576-581.
36. Surh C.D., Sprent J. Homeostasis of naive and memory T cells. Immunity 2008, 29:848-862.
37. Aguado E., Richelme S., Nunez-Cruz S., Miazek A., Mura A.M., Richelme M., Guo X.J., Sainty D., He H.T., Malissen B., Malissen M. Induction of T helper type 2 immunity by a point mutation in the LAT adaptor. Science 2002, 296:2036-2040.
38. McCoy K.D., Harris N.L., Diener P., Hatak S., Odermatt B., Hangartner L., Senn B.M., Marsland B.J., Geuking M.B., Hengartner H., Macpherson A.J., Zinkernagel R.M. Natural IgE production in the absence of MHC Class II cognate help. Immunity 2006, 24:329-339.
39. Sommers C.L., Park C.S., Lee J., Feng C., Fuller C.L., Grinberg A., Hildebrand J.A., Lacana E., Menon R.K., Shores E.W., Samelson L.E., Love P.E. A LAT mutation that inhibits T cell development yet induces lymphoproliferation. Science 2002, 296:2040-2043.
40. Min B., Foucras G., Meier-Schellersheim M., Paul W.E. Spontaneous proliferation, a response of naive CD4 T cells determined by the diversity of the memory cell repertoire. Proc. Natl. Acad. Sci. USA 2004, 101:3874-3879.
41. King C., Ilic A., Koelsch K., Sarvetnick N. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 2004, 117:265-277.
42. Jang E., Kim H.R., Cho S.H., Paik D.J., Kim J.M., Lee S.K., Youn J. Prevention of spontaneous arthritis by inhibiting homeostatic expansion of autoreactive CD4+ T cells in the K/BxN mouse model. Arthritis Rheum. 2006, 54:492-498.
43. Marleau A.M., Sarvetnick N. T cell homeostasis in tolerance and immunity. J. Leukoc. Biol. 2005, 78:575-584.
44. Villa A., Santagata S., Bozzi F., Giliani S., Frattini A., Imberti L., Gatta L.B., Ochs H.D., Schwarz K., Notarangelo L.D., Vezzoni P., Spanopoulou E. Partial V(D)J recombination activity leads to Omenn syndrome. Cell 1998, 93:885-896.
45. Villa A., Notarangelo L.D., Roifman C.M. Omenn syndrome: inflammation in leaky severe combined immunodeficiency. J. Allergy Clin. Immunol. 2008.
46. Chilosi M., Facchetti F., Notarangelo L.D., Romagnani S., Del Prete G., Almerigogna F., De Carli M., Pizzolo G. CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: evidence for a T helper 2-mediated condition. Eur. J. Immunol. 1996, 26:329-334.
47. Chilosi M., Facchetti F., Notarangelo L.D., Romagnani S., Del Prete G., Almerigogna F., De Carli M. The pathology of Omenn's syndrome. Am. J. Surg. Pathol. 1996, 20:773-774.
48. Harville T.O., Adams D.M., Howard T.A., Ware R.E. Oligoclonal expansion of CD45RO+T lymphocytes in Omenn syndrome. J. Clin. Immunol. 1997, 17:322-332.
49. Brooks E.G., Filipovich A.H., Padgett J.W., Mamlock R., Goldblum R.M. T-cell receptor analysis in Omenn's syndrome: evidence for defects in gene rearrangement and assembly. Blood 1999, 93:242-250.
50. Rieux-Laucat F., Bahadoran P., Brousse N., Selz F., Fischer A., Le Deist F., De Villartay J.P. Highly restricted human T cell repertoire in peripheral blood and tissue-infiltrating lymphocytes in Omenn's syndrome. J. Clin. Invest. 1998, 102:312-321.
51. Duke S.G., McGuirt W.F., Jewett T., Fasano M.B. Velocardiofacial syndrome: incidence of immune cytopenias. Arch. Otolaryngol. Head Neck Surg. 2000, 126:1141-1145.
52. Davies K., Stiehm E.R., Woo P., Murray K.J. Juvenile idiopathic polyarticular arthritis and IgA deficiency in the 22q11 deletion syndrome. J. Rheumatol. 2001, 28:2326-2334.
53. Kawamura T., Nimura I., Hanafusa M., Fujikawa R., Okubo M., Egusa G., Amakido M. DiGeorge syndrome with Graves' disease: a case report. Endocr. J. 2000, 47:91-95.
54. Kawame H., Adachi M., Tachibana K., Kurosawa K., Ito F., Gleason M.M., Weinzimer S., Levitt-Katz L., Sullivan K., McDonald-Mcginn D.M. Graves' disease in patients with 22q11.2 deletion. J. Pediatr. 2001, 139:892-895.
55. Staple L., Andrews T., McDonald-McGinn D., Zackai E., Sullivan K.E. Allergies in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) and patients with chronic granulomatous disease. Pediatr. Allergy Immunol. 2005, 16:226-230.
56. Gennery A.R., Barge D., O'Sullivan J.J., Flood T.J., Abinun M., Cant A.J. Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome. Arch. Dis. Child. 2002, 86:422-425.
57. Smith C.A., Driscoll D.A., Emanuel B.S., McDonald-McGinn D.M., Zackai E.H., Sullivan K.E. Increased prevalence of immunoglobulin A deficiency in patients with the chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Clin. Diagn. Lab. Immunol. 1998, 5:415-417.
58. Schubert M.S., Moss R.B. Selective polysaccharide antibody deficiency in familial DiGeorge syndrome. Ann. Allergy 1992, 69:231-238.
59. Finocchi A., Di Cesare S., Romiti M.L., Capponi C., Rossi P., Carsetti R., Cancrini C. Humoral immune responses and CD27+ B cells in children with DiGeorge syndrome (22q11.2 deletion syndrome). Pediatr. Allergy Immunol. 2006, 17:382-388.
60. Haire R.N., Buell R.D., Litman R.T., Ohta Y., Fu S.M., Honjo T., Matsuda F., de la Morena M., Carro J., Good R.A., Litman G.W. Diversification, not use, of the immunoglobulin VH gene repertoire is restricted in DiGeorge syndrome. J. Exp. Med. 1993, 178:825-834.
61. Junker A.K., Driscoll D.A. Humoral immunity in DiGeorge syndrome. J. Pediatr. 1995, 127:231-237.
62. Etzioni A., Pollack S. Hypogammaglobulinaemia in DiGeorge sequence [letter; comment]. Eur. J. Pediatr. 1989, 149:143-144.
63. Garcia Miranda J.L., Otero Gomez A., Varela Ansedes H., Rancel Torres N., Gonzalez Espinosa C., Cortabarria C., Sanchez Salgado G. Monosomy 22 with humoral immunodeficiency: is there an immunoglobulin chain deficit?. J. Med. Genet. 1983, 20:69-72.
64. Prevost-Blondel A., Lengagne R., Letourneur F., Pannetier C., Gomard E., Guillet J.G. In vivo longitudinal analysis of a dominant TCR repertoire selected in human response to influenza virus. Virology 1997, 233:93-104.
65. Pannetier C., Cochet M., Darche S., Casrouge A., Zoller M., Kourilsky P. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments. Proc. Natl. Acad. Sci. USA 1993, 90:4319-4323.
66. Sutter J.A., Kwan-Morley J., Dunham J., Du Y.Z., Kamoun M., Albert D., Eisenberg R.A., Luning Prak E.T. A longitudinal analysis of SLE patients treated with rituximab (anti-CD20): factors associated with B lymphocyte recovery. Clin. Immunol. 2008, 126:282-290.
67. Price G.W., Hogan A.D., Farris A.H., Burks A.W., Platts-Mills T.A., Heymann P.W. Sensitization (IgE antibody) to food allergens in wheezing infants and children. J. Allergy Clin. Immunol. 1995, 96:266-270.
68. Cancrini C., Romiti M.L., Finocchi A., Di Cesare S., Ciaffi P., Capponi C., Pahwa S., Rossi P. Post-natal ontogenesis of the T-cell receptor CD4 and CD8 Vbeta repertoire and immune function in children with DiGeorge syndrome. J. Clin. Immunol. 2005, 25:265-274.
69. Pierdominici M., Marziali M., Giovannetti A., Oliva A., Rosso R., Marino B., Digilio M.C., Giannotti A., Novelli G., Dallapiccola B., Aiuti F., Pandolfi F. T cell receptor repertoire and function in patients with DiGeorge syndrome and velocardiofacial syndrome. Clin. Exp. Immunol. 2000, 121:127-132.
70. Pierdominici M., Mazzetta F., Caprini E., Marziali M., Digilio M.C., Marino B., Aiuti A., Amati F., Russo G., Novelli G., Pandolfi F., Luzi G., Giovannetti A. Biased T-cell receptor repertoires in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Clinical & Experimental. Immunology 2003, 132:323-331.
71. Pirovano S., Mazzolari E., Pasic S., Albertini A., Notarangelo L.D., Imberti L. Impaired thymic output and restricted T-cell repertoire in two infants with immunodeficiency and early-onset generalized dermatitis. Immunol. Lett. 2003, 86:93-97.
72. Sullivan K.E., McDonald-McGinn D., Zackai E.H. CD4(+) CD25(+) T-cell production in healthy humans and in patients with thymic hypoplasia. Clin. Diagn. Lab. Immunol. 2002, 9:1129-1131.
73. Jacquot S., Macon-Lemaitre L., Paris E., Kobata T., Tanaka Y., Morimoto C., Schlossman S.F., Tron F. B cell co-receptors regulating T cell-dependent antibody production in common variable immunodeficiency: CD27 pathway defects identify subsets of severely immuno-compromised patients. Int. Immunol. 2001, 13:871-876.
74. Bernasconi N.L., Traggiai E., Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002, 298:2199-2202.
75. Campbell J., Knutsen A. Decreased CD27+ memory B cells in Digeorge anomaly. Pediatr. Asthma Allergy Immunol. 2008, 21:6-13.
76. Cuss A.K., Avery D.T., Cannons J.L., Yu L.J., Nichols K.E., Shaw P.J., Tangye S.G. Expansion of functionally immature transitional B cells is associated with human-immunodeficient states characterized by impaired humoral immunity. J. Immunol. 2006, 176:1506-1516.
77. Warnatz K., Denz A., Drager R., Braun M., Groth C., Wolff-Vorbeck G., Eibel H., Schlesier M., Peter H.H. Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 2002, 99:1544-1551.
78. Wehr C., Kivioja T., Schmitt C., Ferry B., Witte T., Eren E., Vlkova M., Hernandez M., Detkova D., Bos P.R., Poerksen G., von Bernuth H., Baumann U., Goldacker S., Gutenberger S., Schlesier M., Bergeron-van der Cruyssen F., Le Garff M., Debre P., Jacobs R., Jones J., Bateman E., Litzman J., van Hagen P.M., Plebani A., Schmidt R.E., Thon V., Quinti I., Espanol T., Webster A.D., Chapel H., Vihinen M., Oksenhendler E., Peter H.H., Warnatz K. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 2008, 111:77-85.
79. Ma C.S., Hare N.J., Nichols K.E., Dupre L., Andolfi G., Roncarolo M.G., Adelstein S., Hodgkin P.D., Tangye S.G. Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells. J. Clin. Investig. 2005, 115:1049-1059.
80. Avanzini M.A., Locatelli F., Dos Santos C., Maccario R., Lenta E., Oliveri M., Giebel S., De Stefano P., Rossi F., Giorgiani G., Amendola G., Telli S., Marconi M. B lymphocyte reconstitution after hematopoietic stem cell transplantation: functional immaturity and slow recovery of memory CD27+ B cells. Exp. Hematol. 2005, 33:480-486.